Steph & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Steph & Co's PFE Position: Q2 2026 in Review
Steph & Co reduced its Pfizer (PFE) stake by 20% in Q2 2026, selling an estimated $11.1K and leaving 1,695 shares worth $40.8K. The position accounts for 0.01% of the portfolio, ranked #192.
Steph & Co first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $412K in Q4 2019. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Steph & Co held 1,695 shares of Pfizer worth $40.8K as of Q2 2026.
- Steph & Co sold 425 Pfizer shares in Q2 2026, an estimated $11.1K.
- Pfizer made up 0.01% of Steph & Co's portfolio in Q2 2026, its #192 holding.
- Steph & Co first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
- Steph & Co's Pfizer position peaked at $412K in Q4 2019.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.